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Article abstract—In seven unrelated patients with a demyelinating motor and sensory neuropathy, we found mutations 
in exons 2 and 3 of the P0 gene. Morphologic examination of sural nerve biopsy specimens showed a demyelinating process 
with onion bulb formation in all cases. In four patients, ultrastructural examination demonstrated uncompacted myelin in 
23 to 68% of the myelinated fibers, which is in agreement with the widely accepted function of P0 as a homophilic adhesion 
molecule. Three patients showed normal compact myelin, but morphology was dominated by the abundant occurrence of 
focally folded myelin. The two divergent pathologic phenotypes exemplify that some mutations act differently on P0 
protein formation or function than others, which is probably determined by site and nature of the mutation in the P0 gene.
NEUROLOGY 1996;47:761-765
Charcot-Marie-Tooth disease type 1 (CMT1), or he­
reditary motor and sensory neuropathy type I 
(HMSN type I), is a demyelinating polyneuropathy, 
with prevailing autosomal dominant inheritance. 
Most autosomal dominant cases map to chromosome 
17 (CMT1A); a minority map to chromosome 1 
(CMT1B) or to another unknown autosome 
(CMT1C). CMT1A usually results from a duplication 
of a 1.5-Mb region on chromosome 17pl2 encompass­
ing the gene for the peripheral myelin protein 
PMP22; a few patients show point mutations in this 
gene (see review in Patel and Lupski1), Recent anal­
ysis of CMT1B families did reveal different point 
mutations in the gene for the major protein of pe­
ripheral myelin, protein zero (P0).2'9 In some sporadic 
patients with a more severe phenotype, formerly 
known as Dejerine-Sottas disease (DS), de novo P0 
mutations have been identified.30*11 Nerve morphol­
ogy in most CMT1B families is designated as “hyper­
trophic demyelinating neuropathy.” One report de­
scribed a demyelinating polyneuropathy with an 
abundant occurrence of focally folded myelin in a 
father and son with a P0 mutation.12 Hypomyelina- 
tion with extensive onion bulb formation dominated 
the pathology in two severely affected de novo muta­
tion cases.10,13,14
We describe, for the first time, two divergent mor­
phologic phenotypes in seven patients with different 
P0 mutations.15
Patients and methods. Mutation screening of P0 exons 
was performed in seven unrelated patients without a du­
plication on chromosome 17pl2, by single-stranded confor­
mation polymorphism (SSCP) analysis, followed by se­
quencing of the relevant DNA region, according to 
previously described protocols.a'3*8,16'18 The reported P0 mu­
tations were not found in 100 unrelated healthy controls. 
All patients suffered from a moderately to prominently 
disabling demyelinating motor and sensory neuropathy 
with marked conduction slowing (table) and had formerly 
undergone a sural nerve biopsy. None of the patients had 
experienced pressure palsies. Patients 1, 5, and 6 used 
wheelchairs from the ages of 35 years, 10 years, and 7 
years, respectively. Patient 3 showed a marked deteriora­
tion from the age of 10 months onward and died unexpect­
edly at the age of 22 months.
Data of patients 1, 4, 5, and 7 are included in previous 
reports.19’21 Patient 2 is a member of family NL-47.3 Sural 
nerve biopsy specimens were prepared for light and elec­
tron microscopic studies and morphometric examinations 
using previously described methods.20
Results. Patient 2, member of a CMT1B family, showed 
a three-buse-pair deletion in the P0 gene, resulting in a 
deletion of the codon for serine 34.3 In the six other pa­
tients we identified a single base change, leading to an 
amino acid substitution in codons 5, 69, 101, and 106 of the 
P0 gene (table). Amino acid numbering was started at the 
first amino acid (He) of the mature P0 protein, after the 29 
amino acids of the signal peptide.22 Different codon 69 sub-
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Table Clinical, electrophysiologic, and morphologic data of patients with different P() mutations
Patient 1 2 3 4 5 6 7
P0 mutation ThrSIle Ser 34 Arg69Cys Arg69His Lys 101 Arg Lys 101 Arg Ilel06Leu
Age at independent walking 3 y normal no 1 y 10 m 2.5 y 2.5 y 2.5 y
Median MNCV (m/s) 8 12 8.5* 19 11 10 7
Age at biopsy 35 y 31 y 14 m 12 y 3 y 3 y 2y
MF density in % of normal! 12 8 46 57 60 38 45
TTFA in % of normalt i 276
- - 230 159 139 180
Demyelinated fibers per 100 MF 9 2 3 6 33 47 11
Onion bulbs per 100 MF 50 58 7 77 13 9 21
% MF + UCM 60 53 23 68 <1 <1 <1
% teased MF + tomacula <1 - - <1 100 100 96
Mean g-ratio of 100 MF§ 0.72 0.72 0.75 0.83 -
:I: Ulnar MNCV.
t Mean density of age-matched controls in numbeiVmm2: 15420 (1—2 y, n = 6); 14170 (2-5 y, n = 6); 10530 (11-20 y, n = 5); 10210 
(¿1-40 y, n = 9).
t  Mi-an TTFA of age-matched controls in mm*: 0.47 (1-2 y, n = 4); 0.61 (2-5 y, n = 4); 0.87 (11-30 y, n = 5); 0.93 (31-70 y, n = 5).
§ Me an of age-matched controls: 0.73 (1-5 y, n = 2); 0.67 (11-20 y, n = 3); 0.66 (21—50 y, n = 3).
MNC /  = motor nerve conduction velocity; MF = myelinated fiber; TTFA ~ total transverse fascicular area; UCM = uncompacted mye­
lin; — = not investigated.
stitutions were identified in the patients 3 and 4. The 
Arg69His substitution of patient 4 was found in two other 
CMT1B families.5-9 The unrelated patients 5 and 6 showed 
an identical mutation in codon 101. These six patients 
were isolated cases; parents of five patients were normal 
by clinical and electrophysiologic examination and analysis 
of parental DNA demonstrated that the amino acid substi­
tutions were de novo mutations. For patient 1 neither the 
parents nor the nine siblings showed clinical signs of CMT. 
Chromosomal DNA was available from live siblings only 
and these did not carry the mutation. Therefore, it is likely 
but not proven that patient 1 also had a de novo mutation. 
The patients were heterozygous carriers of the mutation, 
concordant with autosomal dominant inheritance, A child 
of patient 4, born in 1992, showed at the age of 2 years 
clumsy motor performances, absent ankle jei’ks, and a me­
dian motor nerve conduction velocity of 21 m/s. DNA inves­
tigation revealed the same Arg69His mutation as in the 
mother.
Light microscopic examination showed in all cases a 
chronic demyelinating process with onion bulb formation. 
Myelinated fiber density was markedly decreased and my­
elinated fiber diameter histograms showed a preferential 
loss of large-diameter fibers» Total transverse fascicular 
area was moderately increased.
Ultrastructural examination in patients 1, 2, 3, and 4 
revealed the presence of uncompacted myelin in 23 to 68% 
of the myelinated fibers. The uncompacted structure was 
commonly seen in the inner layers of the myelin sheath, 
but occasionally it was seen in the outer lamellae as well 
(figure 1A). At the transitional zone between compacted 
and uncompacted myelin, the major dense lines split to 
enclose thin layers of Schwann cell cytoplasm, sometimes 
with adherens junctions23 (figure IB). Usually, the intra- 
period distance was slightly broadened and sometimes par­
tial fusion of the extracellular membranes occurred over a 
short distance (figure 1C). Schniidt-Lanterman incisures
were frequent and abnormally wide* Occasionally, they 
could not be distinguished from areas of uncompacted my­
elin. In patients 1 and 4 several fibers showed undulating 
major dense lines with dilatation of intraperiod lines only 
(figure ID). The compacted parts of the sheaths showed a 
normal periodicity of myelin. Myelin-like figures were of­
ten seen between the uncompacted lamellae, suggestive of 
incipient myelin degradation (see figure IB). Several demye­
linated fibers were present; tomacula occurred sporadically 
in the patients 1 to 4. Onion bulb formations occurred 
rather frequently in the older patients and were composed 
of thin Schwann cell lamellae. The myelin sheath of nearly 
all fibers was too thin for the axon diameter, witness the 
high g-ratios (axon diameter: fiber diameter) (see table).
In patients 5, 6, and 7 the occurrence of many folded 
myelin loops (tomacula) dominated the pathology (figure 
2). In longitudinal sections excessive folded myelin ap­
peared to pass into thin myelin sheaths within the same 
internode. Fibers outside tomacula were frequently demy­
elinated or thinly (re)myelinated. Onion bulbs were com­
posed of thin Schwann cell layers and contained many 
double basement membranes, especially in case 7. Uncom­
pacted myelin was encountered only in a few fibers. In­
volvement of unmyelinated axons was not obvious in either 
morphologic type.
Discussion. We investigated nerve pathology in 
seven patients with different mutations in the P0 
gene. The clinical phenotypes ranged from a severe, 
infantile neuropathy with very low conduction veloc­
ities to a milder neuropathy with later onset. The 
severe, infantile cases might be classified as DS dis­
ease, although they do not show an autosomal reces­
sive inheritance, which is part of the original con­
cept.24 In the future, it would be preferable to classify 
the inherited neuropathies not by clinical and elec-
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